Medtronic pushes Hugo toward broader U.S. adoption as robotic surgery competition intensifies
Medtronic’s Hugo filings could widen U.S. robotic surgery competition. Find out how the FDA review may challenge Intuitive Surgical.
Medtronic’s Hugo filings could widen U.S. robotic surgery competition. Find out how the FDA review may challenge Intuitive Surgical.
Find out how Reach Surgical’s Sound Reach Swift CE Mark approval could reshape open surgery energy device workflows in Europe.
DePuy Synthes wants to remove a robotics bottleneck. Its Gemtrack deal could change joint surgery navigation if regulators agree.
GHO Capital and CBC Group are creating a $21bn healthcare investor. Find out what it means for pharma, medtech and life sciences funding.
Find out how Hyperfine’s PRIME study could reshape emergency brain imaging with faster bedside portable MRI access.
Align needs growth and supply-chain efficiency. Its Hyderabad factory could turn India into a larger digital dentistry manufacturing base.
Chronic pain care needs non-opioid options. Medtronic’s SPR Therapeutics deal tests whether temporary PNS can scale beyond niche adoption.
Ureteral stones need faster care. Avvio Medical’s outpatient device tests whether microbubble lithotripsy can ease OR bottlenecks.
HistoSonics cleared Taiwan, but the bigger test is whether histotripsy can scale from liver tumors into broader oncology use.
EBUS imaging is clinically valuable, but workflow remains messy. Fujifilm’s EB-710US tests whether simpler design can change adoption.